Article Information
History
- December 8, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Rachel K. Rosenstein1,
- Jeremy J. Rose2,
- Stephen R. Brooks3,
- Wanxia L. Tsai4,
- Massimo Gadina4,
- Steven Z. Pavletic5,
- Keisuke Nagao6 and
- Edward W. Cowen7,*
- 1Center for Discovery and Innovation and Department of Medicine, Hackensack Meridian School of Medicine, Nutley, NJ 07110, USA
- 2BlueRock Therapeutics, NY, NY 10016, USA
- 3Biodata Mining and Discovery Section, Office of Science and Technology, NIAMS, NIH, Bethesda, MD 20892, USA
- 4Translational Immunology Section, NIAMS, NIH, Bethesda, MD 20892, USA
- 5Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA
- 6Cutaneous Leukocyte Biology Section, Dermatology Branch, NIAMS, NIH, Bethesda, MD 20892, USA
- 7Dermatology Branch, NIAMS, NIH, Bethesda, MD 20892, USA
- ↵*Corresponding Author; email: cowene{at}mail.nih.gov
Posted December 08, 2022.
Identification of fibroinflammatory and fibrotic transcriptomic subsets of human sclerotic cutaneous chronic graft-versus-host disease
